Graves' disease, the production of thyroid-stimulating hormone receptor-stimulating antibodies leading to hyperthyroidism, is one of the most common forms of human autoimmune disease. It is widely agreed that complex diseases are not controlled simply by an individual gene or DNA variation but by their combination. Single nucleotide polymorphisms (SNPs), which are the most common form of DNA variation, have great potential as a medical diagnostic tool. In this paper, the P-value is used as a SNP pre-selection criterion, and a wrapper algorithm with binary particle swarm optimization is used to find the rule for discriminating between affected and control subjects. We analyzed the association between combinations of SNPs and Graves' disease by investigating 108 SNPs in 384 cases and 652 controls. We evaluated our method by differentiating between cases and controls in a five-fold cross validation test, and it achieved a 72.9% prediction accuracy with a combination of 17 SNPs. The experimental results showed that SNPs, even those with a high P-value, have a greater effect on Graves' disease when acting in a combination.
Graves' disease (GD) is one of the most common forms of human autoimmune disease, with an estimated frequency of up to 1.3% (0.5% clinical and 0.7% subclinical) in the United States [1] and 0.25%-1.09% in China [2] . GD is caused by the production of thyroid-stimulating hormone receptor-stimulating antibodies leading to hyperthyroidism [3] . DNA variations in the human genome, which alter physiological pathways, are considered the primary risk factors for many diseases. Single-nucleotide polymorphisms (SNPs) are the most common form of DNA variation [4] . It is estimated that there are approximately 12 million SNPs in the human genome [5] . Although most are neutral, certain SNPs can affect phenotypes such as height, skin color, resistance to infection and susceptibility to disease [6] .
Understanding the mechanisms underlying diseases will contribute to the development of future therapies. In the past few decades, association studies have identified some associations between genetic variants and diseases or human phenotypes [7, 8] , but the evaluation of combinations of SNPs has been less commonly addressed. Studies show that while individual SNPs may make a very small contribution to disease, combinations of SNPs can be strongly associated with complex diseases [9] . Similarly, GD is modestly affected by single SNPs, but might be greatly affected by a combination of SNPs. One of the major goals of association studies is to identify the combinations of SNPs that lead to higher disease risk. The aim of this paper is to identify the rules for classifying the case (GD) and control (non-GD) groups. Because of the combinatorial explosion of the number of subsets, exhaustive enumeration was impractical for this study.
Recently, there have been several reports examining the effects of SNPs on disease [10, 11] . Wan et al. [9] developed an alternative learning approach to select the important SNPs for disease. Kusiak and Shah [12] identified the SNPs that optimally predict the risk of disease by minimizing the classification error. Xie et al. [13] presented an adaptation of the decision forest pattern recognition algorithm for esophageal cancer association studies. Yasuyuki et al. [14, 15] evaluated SNPs to predict the risk of allergic asthma. However, due to the non-deterministic polynomial-time-hard nature of this problem, these methods typically suffer from inefficiency and inaccuracy problems. In addition, the P-value has been seldom used in most of the previous studies.
In this paper, we propose a wrapper algorithm with binary particle swarm optimization to analyze the association between combinations of SNPs and GD, whose classifier is a two-layer linear classifier (TLC). Binary particle swarm optimization (BPSO) is used as a feature selection method to identify the combination of SNPs, and the TLC (optimized by particle swarm optimization (PSO)) is used to predict the susceptibility to disease. In addition, the P-value was used as the pre-selection criterion. In this study, we investigated 108 SNPs in major GD-related pathways in 384 cases and 652 controls. We achieved a 72.9% prediction accuracy with a combination of 17 SNPs. Experimental results demonstrate the feasibility of incorporating our method into a case-control study.
Materials and methods

Data
The dataset used in this paper was supplied by Dr. Dumitru Brinza [16] . The dataset was derived from 330 kb of human DNA sequence containing the genes CD28, CTLA4 and ICOS, which are related to GD [17] . A total of 108 SNPs were genotyped in 384 cases and 652 controls [17] .
Particle swarm optimization
PSO is an iterative optimization algorithm inspired by the observation of collective behaviors in animals (e.g., bird flocking) [18] . In PSO, each candidate solution to an optimization problem is represented by one particle. Each particle i is described by its position x i and velocity v i . The algorithm starts with random initialization of the particles. Then, the particles change their positions according to their velocities, which update in each iteration. Given that p i is the best position found by particle i in all the preceding iterations and p g is the best position found so far by the entire swarm, the velocity and position of particle i in bit j will be updated according to the following formulae:
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where r 1 and r 2 are random numbers between 0 and 1, and c 1 and c 2 define the degree of influence of p i and p g on the particle's velocity. The velocity v ij is bounded within a range of max max
[ , ] V V − to prevent the particle from flying out of the solution space.
Binary particle swarm optimization
Because many optimization problems are set in a discrete space, Kennedy and Eberhart [19] extended the PSO to a BPSO in 1997. In BPSO, a particle moves in a state space restricted to 0 or 1 in each bit, where v ij represents the probability of the bit x ij taking the value 1. Therefore, v ij must be constrained to the interval [0.0, 1.0] . A logistic transformation S(v ij ) can be used to accomplish this modification, and the position update function is defined as follows: 
BPSO-TLC with a P-value filter algorithm
The proposed algorithm consists of two parts: the P-value filter approach and the BPSO-TLC wrapper approach. First, the P-value is used to filter the sub-dataset. The P-value filter is a preprocessing method that is used to decrease the size of the feature space. The smaller the P-value of a SNP, the more relevant it is to GD. Thus, if the P-value of any SNP is smaller than the threshold value, the SNP is selected. Otherwise, the SNP is removed.
Next, BPSO-TLC is used to optimize the performance of the selected SNPs. Because combining the best individual SNPs may not yield the best set, BPSO-TLC is used to find the 'optimal' SNP subset. BPSO-TLC contains two main steps. The first step entails the selection of a set of SNPs by BPSO (particles in BPSO represent the features mask, where a bit with value '1' indicates that the SNP is selected and '0' indicates that it is not selected). Then, in the second step, the selected SNPs are passed to the TLC classifier to acquire a fitness value for each particle of BPSO, while the product of the genotype and its corresponding P-value is the input for the TLC. The procedure for the TLC classifier is shown in Figure 1 .
The classification rule is defined as follows: 
where s ki is the genotype (1 and 2 represent sites homozygous for the major and minor alleles, respectively, and 3 represents the heterozygous sites) of the ith SNP in the kth sample; λ i is the P-value of the ith SNP; w i is the weight value (the value of the PSO particle in bit i) of the ith SNP. i y ∈ − + (-1 represents the cases and +1 represents the controls).
Initialize:
Generate M velocity and position vectors randomly for PSO;
Generate N velocity and position vectors randomly for BPSO;
Repeat until the termination criteria are met (the maximum number of iterations);
Obtain the feature subset from the BPSO and P-value filtering method; Train the TLC classifier: Calculate the value of the function (4); Calculate the fitness value (the prediction accuracy) of PSO;
Update the PSO velocity and position vectors according to (1) and (2), respectively. 
Test the TLC classifier:
Calculate the fitness value of BPSO; Update BPSO velocity and position vectors according to (1) and (3), respectively.
Output:
The best BPSO particle and corresponding weight vector (PSO particle).
Cross-validation
The k-fold method [20] was employed in the experiments, with the value of k set to five. For five-fold cross-validation, the whole dataset was divided into five subsets with approximately equal size. Then, the classifier was trained five times--each time, one subset was used as the testing data to validate the classifier.
Results
Based on previous research [21, 22] 
where TN, TP, FN, and FP refer to true negative (TN), number of controls that were correctly classified as control; true positive (TP), number of cases that were correctly classified as case; false negative (FN), number of cases that were wrongly classified as control; and false positive (FP), number of controls that were wrongly classified as case, respectively. We performed our algorithm to identify the combination of SNPs most highly associated with GD (Table 1 ). The accuracy of classification was 70.6% with the entire set of 108 SNPs, and better results were obtained when the P-value filter was used. However, the SNP subset with the lowest P-value (P<0.001) did not yield the best result. This might be attributable to the different effects of a single SNP and a combination of SNPs. That is, the P-value filter method can reduce the search space from a large number of all possible combinations to a manageable one; however, the interdependence among SNPs is ignored. Figure 2 shows the classification accuracy and SNPs selected with different P-values. The highest prediction accuracy obtained by our method was 72.9%, with a combination of 17 SNPs, each with P<0. 3 . The details of these SNPs are shown in Table 2 . Figure 3 shows the number of iterations vs. prediction accuracy and the number of iterations vs. SNPs selected. The number of SNPs selected converges at the later stages; however, the prediction accuracy keeps improving. The reason for this is that the actual SNPs selected can be different even if the total number is the same. The prediction accuracy of our method is higher than that of some previous studies, for example, 69% in Listgarten et al.'s study [23] or 67.5% in Uhmn et al.'s study [24] . Although these previous studies used different disease samples, and it is, therefore, difficult to compare the prediction accuracy directly, the performance of our algorithm is acceptable.
To verify the effectiveness of our algorithm, we compared its performance with that of other current methods (Table 3) . It is clear that our algorithm outperforms other methods. The accuracy obtained by our method was 72.9%, whereas C4.5, RandForest, NB and SVM obtained only 61.2%, 62.3%, 58.4% and 66.4%, respectively.
For further comparison, we used two published methods, IBPSO and HPG [21, 22] on our GD dataset. The parameters used were as in [21, 22] , respectively. Table 4 shows the sensitivity, specificity and accuracy obtained by these algorithms. It can be seen that our algorithm yielded a higher Figure 4 after normalization. CTAF450_1, CTAF450_4 and JO34 strongly correlate with GD.
The frequencies of the three genotypes of the 17 selected SNPs in the case and control datasets are shown in Figure 5 . The frequencies of genotype 1 (homozygosity for the major allele) at SNPs MH13_1, CT60, JO36 and JO18 1 are much higher in the control group than in the case group. Therefore, these SNPs may exert protective effects against GD. The frequency of genotype 2 (homozygosity for the minor allele) at CTAF343 is clearly different between the two groups. The frequencies of genotype 3 (heterozygosity) at JO37_2, JO13, JO3, CTBC053 and CT_C065 are much higher in the case group than their corresponding control group frequencies. When the genotype frequencies in cases are greater than those in the controls, that combination of SNPs is regarded as a risk factor; the opposite implies a protective factor.
Conclusion
The large number of SNPs makes disease association stud- ies difficult to conduct. In this paper, we have proposed a wrapper algorithm with a P-value filter to detect multiple disease-associated SNPs. For a single SNP, it is commonly agreed that the smaller its P-value, the more relevant it is to disease. However, this is not always true for combinations of SNPs. Our study shows that a SNP in a combination, whose P-value is smaller than an optimal threshold (not a very small value), has a greater effect on GD than the single SNP with the lowest P-value. In addition, we have demonstrated that our method is an effective tool for the identification of combinations of SNPs in association studies of GD. 
